You are here

Magazine

15

A randomized controlled trial comparing a xyloglucan-based nasal spray with saline in adults with symptoms of rhinosinusitis.

Allegrini A et al.

“A clinical trial recently published assessed the efficacy, safety and tolerability of a xyloglucan-based nasal spray (Rhinosectan) in the treatment of rhinosinusitis, and concluded that this medical device provided greater relief of symptoms than a physiological saline spray”. Allegrini A et al. A randomized controlled trial comparing a xyloglucan-based nasal spray with saline in adults with symptoms of rhinosinusitis. Current Medical Research and Opinion, 2017. DOI: 0.1080/03007995.2017.1341402

Read more

New publication on Tasectan Duo

L. Lopetuso, C. Graziani, A. Guarino, A. Lamborghini, S. Masi, V. Stanghellini

Eur Rev Med Pharmacol Sci . 2017; 21 (4): 873-883Researchers from the A. Gemelli Foundation, School of Medicine, Rome, Italy have published an extensive review on the role of Gelatin tannate and tyndallized probiotics (Tasectan Duo) in the treatment of diarrhea.https://www.ncbi.nlm.nih.gov...

Read more

The combination of oligo- and polysaccharides and reticulated protein for the control of symptoms in patients with irritable bowel syndrome: Results of a randomised, placebo-controlled, double-blind, parallel group, multicentre clinical trial.

Octavian Alexea, Vlad Bacarea and Nuria Pique.

Treatment with oligo- and polysaccharides and reticulated protein is safe, improving IBS symptoms and quality of life of patients with diarrhoea-predominant IBS.

Read more

Let's meet in..

2021, Mar 29

Europharm SMC

Read more

2021, May 27

PharmaVenue Berlin

Read more